Aycan ÜNALP, Selvinaz EDİZER, Orkide GÜZEL, Hande TÜRKYILMAZ

Evaluation of polyneuropathy and associated risk factors in children with type 1 diabetes mellitus

Background/aim: Diabetes mellitus (DM) is one of the most common metabolic diseases seen in the world today. Diabetic neuropathy (DN) is a chronic complication of the disease that is rarely reported in children, since it has a relatively longer latency period. Our main objective in this study is to determine the incidence rate of DN in pediatric DM patients and assess the risk factors associated with DN. Materials and methods: Data from 111 patients from January 2011 to May 2014 were reviewed in a retrospective manner. Nerve conduction studies were performed as the gold standard in diagnosis. Results: The incidence rate of symptomatic DN was 13.5% according to our study results. The EMG-diagnosed DN incidence rate was calculated as 22.5%. Following linear regression analysis, positive correlation was found between diabetes duration, diabetic ketoacidosis, and DN presence. Conclusion: Our study results demonstrate the fact that poor metabolic control, especially during early stages of the disease, is a major risk factor for neuropathy development. Planning prospective studies with long-term evaluations on nerve conduction in children with DM will be beneficial for this subject.

PDF

___

1. Vinik AI. Diabetic neuropathy: pathogenesis and therapy. Am J Med 1999; 107: 17-26.
2. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150-154.
3. Dyck PJ, Thomas PK. Peripheral Neuropathy. 3rd ed. Philadelphia, PA, USA: W.B. Saunders Company; 1993.
4. Höliner I, Haslinger V, Lütschg J, Müller G, Barbarini DS, Fussenegger J, Zanier U, Saely CH, Drexel H, Simma B. Validity of the neurological examination in diagnosing diabetic peripheral neuropathy. Pediatr Neurol 2013; 49: 171-177.
5. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, IonescuTirgoviste C, Witte DR, Fuller JH; EURODIAB Prospective Complications Study Group. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005; 352: 341-350.
6. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
7. Hanssen KF. Blood glucose control and microvascular and macrovascular complications in diabetes. Diabetes 1997; 46: 101-103.
8. Gökşen Şimşek D, Aycan Z, Özen S, Çetinkaya S, Kara C, Abalı S, Demir K, Tunç Ö, Uçaktürk A, Asar G et al. Diabetes care, glycemic control, complications, and concomitant autoimmune diseases in children with type 1 diabetes in Turkey: a multicenter study. J Clin Res Pediatr Endocrinol 2013; 5: 20-26.
9. Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ 3rd, OBrien PC. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 1999; 22: 1479-1486.
10. Hyllienmark L, Alstrand N, Jonsson B, Ludvigsson J, Cooray G, Wahlberg-Topp J. Early electrophysiological abnormalities and clinical neuropathy: a prospective study in patients with type 1 diabetes. Diabetes Care 2013; 36: 3187-3194.
11. Charles M, Soedamah-Muthu SS, Tesfaye S, Fuller JH, Arezzo JC, Chaturvedi N, Witte DR; EURODIAB Prospective Complications Study Investigators. Low peripheral nerve conduction velocities and amplitudes are strongly related to diabetic microvascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 2010; 33: 2648-2653.
12. Marcus J, Ehrlich R, Kelly M, Murphy EG. Nerve conduction in childhood diabetes. Can Med Assoc J 1973; 108: 1116-1119.
13. Gregersen G. Variations in motor conduction velocity produced by acute changes of the metabolic state in diabetic patients. Diabetologia 1968; 4: 273-277.
14. Gregersen G. Diabetic neuropathy: influence of age, sex, metabolic control and duration of diabetes on motor conduction velocity. Neurology 1967; 17: 972-980.
15. Chantraine A, Hamoir JP, Balthazar-Letawe D. Electromyography and speed of motor conduction in 150 cases of diabetes. Electromyography 1968; 8: 257-262 (in French).
16. Gamstorp I, Shelburne SA Jr, Engleson G, Redondo D, Traisman HS. Peripheral neuropathy in juvenile diabetes. Diabetes 1966; 15: 411-418.
17. Ellenberg M. Diabetic neuropathy presenting as the initial clinical manifestation of diabetes. Ann Intern Med 1958; 49: 620-631.
18. Samahy MH, Elbarbary NS, Elmorsi HM. Current status of diabetes management, glycemic control and complications in children and adolescents with diabetes in Egypt. Where do we stand now? And where do we go from here? Diabetes Res Clin Pract 2015; 107: 370-376.